Soc. Generale Knock-Out MRK/ DE000CL7PKQ0 /
29/05/2024 09:57:29 | Chg.+0.270 | Bid10:29:24 | Ask10:29:24 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
7.860EUR | +3.56% | 7.940 Bid Size: 10,000 |
7.950 Ask Size: 10,000 |
MERCK KGAA O.N. | 91.2382 - | 31/12/2078 | Call |
GlobeNewswire
28/05
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
GlobeNewswire
07/05
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
06/05
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
04/03
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
21/12/2023
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
14/12/2023
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
17/10/2023
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA